Larvol Delta - Allakos-Announces-Positive-Interim-Results-from-an-OpenLabel-Extension-Study-of-Antolimab-AK002-in-Patients-with-Eosinophilic-Gastritis-andor-Eosinophilic-Duodenitis

antolimab (AK002) - Allakos

http://www.globenewswire.com/news-release/2020/05/04/2026713/0/en/Allakos-Announces-Positive-Interim-Results-from-an-Open-Label-Extension-Study-of-Antolimab-AK002-in-Patients-with-Eosinophilic-Gastritis-and-or-Eosinophilic-Duodenitis.html

May 4, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next